Loan & DebtJun 5, 2026, 05:06 PM
Trinity Biotech Capitalizes May 2026 Interest, Gets Lender Waiver
AI Summary
Trinity Biotech PLC has reached an agreement with its lender, Perceptive Credit Holdings III, LP, to capitalize the interest payable for May 2026. This interest will be added to the outstanding principal balance of the credit agreement. Additionally, Perceptive has provided a limited waiver concerning Section 8.15 of the credit agreement for June 2026.
Key Highlights
- Trinity Biotech agreed with Perceptive Credit Holdings III, LP to capitalize May 2026 interest.
- The May 2026 interest will be added to the principal balance outstanding.
- Perceptive granted a limited waiver for Section 8.15 of the credit agreement for June 2026.
Price Impact
More from TRIB